Related Experiment Video
Updated: Jul 4, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Medicare disease management in policy context
Ariel Linden1, Julia Adler-Milstein
1Oregon Health & Science University, USA. alinden@lindenconsulting.org
Abstract:
Interim results of the Medicare health support (MHS) demonstration projects suggest that commercial disease management (DM) is unable to deliver short-term medical cost savings. This is not surprising given the current DM program focus on compliance with process measures that may only lead to cost savings in the long-term. A program focused on reducing near-term hospitalizations is more likely to deliver savings during the initial 3-year phase of MHS. If the early trends in MHS are indicative of the final results, CMS will face the decision of whether to abandon commercial DM in favor of other chronic care management strategies. This article supports the upcoming assessment by describing the characteristics of the current commercial DM model that limit its ability to deliver short-term medical cost savings and the changes required to overcome these limitations.
Insights
Commercial disease management (DM) programs struggle with short-term cost savings. Focusing on reducing hospitalizations could improve Medicare health support (MHS) outcomes.
Area of Science:
- Health Economics
- Chronic Care Management
- Healthcare Policy
Background:
- Medicare health support (MHS) demonstration projects are evaluating disease management (DM) cost-effectiveness.
- Current DM programs often prioritize process measures, potentially delaying medical cost savings.
Purpose of the Study:
- To analyze why commercial DM models fail to achieve short-term medical cost savings.
- To identify necessary changes in DM strategies for improved near-term financial returns within MHS.
Main Methods:
- Analysis of interim results from MHS demonstration projects.
- Examination of the characteristics of current commercial DM models.
- Assessment of the impact of process measures versus outcome-based interventions.
Main Results:
- Interim MHS data indicate commercial DM is not delivering short-term medical cost savings.
- The focus on process compliance in DM may hinder immediate financial benefits.
- Programs targeting near-term hospitalization reduction show greater potential for savings.
Conclusions:
- Commercial DM, as currently structured, is unlikely to yield short-term cost savings in MHS.
- A shift towards outcome-focused strategies, particularly hospitalization reduction, is recommended for MHS.
- Policymakers may need to reconsider commercial DM in favor of alternative chronic care management approaches.
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Therapeutic Drug Monitoring: Affecting Factors